ASO Author Reflections: Stage-Adjusted Reduced Follow-Up of Melanoma Patients is Justified and Cost Effective, Until Biomarkers to Predict Prognosis Have Been Identified

Detalles Bibliográficos
Autores principales: Francken, Anne Brecht, Hoekstra-Weebers, Josette E. H. M., Deckers, Eric, Hoekstra, Harald J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
ASO Author Reflections
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138777/
https://www.ncbi.nlm.nih.gov/pubmed/31482389
http://dx.doi.org/10.1245/s10434-019-07611-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138777/
https://www.ncbi.nlm.nih.gov/pubmed/31482389
http://dx.doi.org/10.1245/s10434-019-07611-5

Ejemplares similares